Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

855
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
855
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

727
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
727
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.7K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.7K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.2K
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ASO Visual Abstract: Do Postoperative Complications Impact Adjuvant Chemotherapy for Patients Undergoing Left-Side Pancreatectomy for Pancreatic Cancer?

Annals of surgical oncology·2026
Same author

Do Postoperative Complications Impact Adjuvant Chemotherapy in Patients Undergoing Left-Side Pancreatectomy for Pancreatic Cancer?

Annals of surgical oncology·2026
Same author

De-Escalating Surgery for 1-2 cm Appendiceal Neuroendocrine Tumors: A North American Multi-Center Analysis.

Journal of surgical oncology·2026
Same author

Longitudinal Incidence and Outcomes of Remnant Cholecystitis after Subtotal Cholecystectomy: An Analysis of 2,682 Patients.

Journal of the American College of Surgeons·2026
Same author

The Association of Extended Venous Thromboembolism Prophylaxis and Venous Thromboembolism After Cancer Surgery.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Long-term quality of life, financial toxicity, and decision regret following therapeutic and prophylactic gastrectomy for cancer.

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·2026
Same journal

Clinical Trials and Translational Advances in Metabolic Targeting.

Cancer treatment and research·2026
Same journal

Tools and Technologies for Studying Cancer Metabolism.

Cancer treatment and research·2026
Same journal

Cancer and Immune Cells: A Metabolic Battle in the Tumor Microenvironment.

Cancer treatment and research·2026
Same journal

Biomarkers of Cancer Metabolism and Therapeutic Response.

Cancer treatment and research·2026
Same journal

Targeting Metabolism in Cancer Therapy: Inhibitors and Approaches.

Cancer treatment and research·2026
Same journal

Metabolic Reprogramming in Cancer Stem Cells.

Cancer treatment and research·2026
See all related articles

Related Experiment Video

Updated: Apr 17, 2026

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

10.5K

Comparative effectiveness research for sarcoma.

Nabil Wasif1

  • 1Department of Surgery, Mayo Clinic Arizona, Phoenix, AZ, USA, wasif.nabil@mayo.edu.

Cancer Treatment and Research
|February 14, 2015
PubMed
Summary
This summary is machine-generated.

Multidisciplinary sarcoma care offers research opportunities. Comparative effectiveness studies should focus on survival, quality of life, and cost-effectiveness to improve patient outcomes.

More Related Videos

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.8K
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

4.5K

Related Experiment Videos

Last Updated: Apr 17, 2026

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

10.5K
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.8K
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

4.5K

Area of Science:

  • Oncology
  • Surgical Oncology
  • Radiotherapy Oncology

Background:

  • Multidisciplinary management is crucial for optimal sarcoma care.
  • Comparative effectiveness research (CER) is needed to evaluate modern sarcoma treatment strategies.
  • Key outcomes for CER include survival, quality of life, and cost-effectiveness.

Purpose of the Study:

  • To summarize the current state of the art in multidisciplinary sarcoma management.
  • To identify opportunities for comparative effectiveness research in sarcoma.
  • To discuss the utility of specialized care and tumor boards.

Main Methods:

  • Literature review and synthesis of current evidence.
  • Discussion of treatment efficacy, sequencing (chemotherapy, radiation, surgery), margin reporting, and surveillance.
  • Identification of future research directions in sarcoma CER.

Main Results:

  • Specialized/regional care and tumor boards are important components of multidisciplinary management.
  • Treatment efficacy and sequencing require further investigation.
  • Standardized margin reporting and surveillance protocols are essential.

Conclusions:

  • Comparative effectiveness research in sarcoma should prioritize patient-centered outcomes.
  • Further research is needed to optimize treatment strategies and care delivery models.
  • Multidisciplinary collaboration is key to advancing sarcoma research and patient care.